text:
Home Perspectives Big Pharma Research Racket Is Killing People
Big Pharma Research Racket Is Killing People
Evelyn Pringle
Over the past six years, ten FDA approved drugs have been withdrawn from the market due to deaths and injuries, leading lawmakers to accuse the FDA of not doing its job in protecting the public from unsafe drugs and to call for measures of improvement.
On June 20, 2006, the New York Times reported that "two influential senators are expected within weeks to introduce a legislative proposal that could drastically change how drugs are tested and approved in the United States."
The Senators behind the proposal are Michael Enzi (R-Wy), chairman of the Health, Education, Labor and Pensions Committee, and Ted Kennedy (D-MA), the ranking Democrat on the committee.
"In broad terms," the Times article by Gardner Harris explains, "the bill would require that drug makers disclose the results of all large human tests of their drugs, known as Phase 3 and Phase 4 trials; create a detailed risk management plan to uncover and control any safety problems that arise after a drug is approved; and pay penalties if they fail to follow through with this plan, according to four experts who were briefed on the proposals."
However, while lawmakers search for ways to ensure that Big Pharma does not continue to conceal adverse reactions that surface during drug trials and to sever the ties between the nation's public health officials and Big Pharma, the Bush administration continues to promote their cozy relationships and help drug companies escape accountability for misconduct.
The best example of the administration's efforts to protect Big Pharma was revealed recently when the FDA announced a preemption rule that would disallow lawsuits in state court against drug makers if a drug has been approved by the FDA.
"We think that if your company complies with the FDA processes, if you bring forward the benefits and risks of your drug, and let your information be judged through a process with highly trained scientists, you should not be second-guessed by state courts that don't have the same scientific knowledge," said FDA deputy commissioner on medical and scientific affairs, Scott Gottlieb.
But in all fairness, the FDA is certainly not the only public health agency in bed with Big Pharma. Nobody can deny the fact that Big Pharma is an equal opportunity corrupter. Its obvious that drug companies have infiltrated every Federal regulatory agency in the US.
For instance, on June 14, 2006, a National Institute of Health Alzheimer's researcher, Dr Trey Sunderland, asserted his Fifth Amendment rights, and refused to testify before the House Energy and Commerce Committee about accusations that he has profited from giving Pfizer access to spinal fluid and plasma samples collected by the NIH.
Documents presented at the hearing revealed that between 1996 an 2004, Dr Sunderland accepted consulting, speaking and advisory fees totaling about $612,000 and committee staff members estimate that about $285,000, was related to 3,245 samples taken from 538 patients who participated as volunteers at the NIH.
At a price of about $12,000 per patient, the committee estimates the cost of collecting the samples that Dr Sunderland handed to Pfizer is close to $6.5 million.
The committee also noted that he did not seek prior approval to work for Pfizer, and did not report any of the income to the agency as required by NIH rules.
In fact, at one point, when asked, Dr Sunderland said he had no outside deals. According to the December 22, 2004 LA Times, while reviewing financial disclosure reports from scientists at the NIH, in March 2000, ethics officer Olga Boikess noticed that Dr Sunderland had not declared any jobs with the industry so she sent him an e-mail that said: "You did not list any outside positions."
To which, Dr Sunderland replied: "I do not have any outside positions to note."
This case had been dragging on for years but the doctor has probably not been too worried because history shows that any time a Republican lawmaker get too pesky about the money trails leading to the NIH, Big Pharma simply offers enough money to induce him to jump ship.
A couple years ago, two Republicans on powerful committees switched sides shortly after they launched investigations into conflicts of interest between drug companies and employees at the NIH.
Representative, WJ "Billy" Tauzin (R-La), was chairman of the House Energy and Commerce Committee, and had cited "secret consulting fees and stock options from drug companies" as reasons to request documentation of all payments from Big Pharma to NIH scientists.
But next thing you know, Tauzin announces that he is not running for reelection, and leaves Congress to become President of the Pharmaceutical Research and Manufacturers of America, the giant trade group that represents Big Pharma, with a reported $2 million a year in salary, benefits and perks.
Next up to bat, was Representative James Greenwood (R-Pa), who led 3 hearings on NIH conflicts of interest and criticized the agency for allowing scientists to use "a swivel chair" to make decisions while taking drug company money.
But low and behold, shortly thereafter, in July 2004, Rep Greenwood announced that he was giving up his post as chairman of the Energy and Commerce subcommittee to retire, only to become President of the Biotechnology Industry Organization, a group that in the same year, urged lawmakers not to bar NIH scientists from entering into paid consulting deals.
A report by the Office of Government Ethics, released the same month that Rep Greenwood announced his "retirement," said the NIH was beset by a "permissive culture," and revealed that 40% of the 155 randomly selected sample payments to agency employees reviewed had not been approved or accounted for within the NIH.
The FDA remains at the top of the list for corruption simply because the FDA evaluates the safety and effectiveness of drugs and decides which drugs can be marketed in the US.
Typically, as a first step toward the approval process, a drug company will initiate laboratory testing to assess the effectiveness and safety of a drug and if the laboratory testing is successful, the company will begin testing the drug on animals. The FDA does not become involved until the drug maker seeks permission to test the drug on humans.
When the drug reaches that point, the FDA's Center for Drug Evaluation and Research, evaluates the results of laboratory and animal testing prior to allowing any study on humans.
Once a drug is approved for testing on humans an Institutional Review Board (IRB) is appointed to review and monitor the research. An IRB is generally made up of outside scientists, doctors and other medical professionals and has the authority to approve or disapprove a study or to require modifications to secure approval of the research.
The purpose of an IRB is to assure that appropriate steps are taken to protect the rights and welfare of human subjects. To that end, an IRB uses a group process to review research protocols and materials such as informed consent documents and investigator brochures related to the research.
In recent years, serious questions have been raised regarding the impartiality of the review process due to the fact that many of the FDA advisors recommending approval of a product are at the same time employed by the drug company that developed the drug or hold some other financial interest link to the company.
Due to these conflicts of interests, critics say dangerous drugs are winning approval. For instance, nearly a third of the members of the advisory panel that reviewed the data on Vioxx, Celebrex and Bextra, and voted to allow the drugs to remain on the market, even after Vioxx had been pulled off the market, had financial ties to the makers of the drugs and had their votes not been counted, they would never have received a vote of approval.
In addition, problems continue to surface in the private research industry. Contract Research Organizations (CRO), are now hired by the industry to perform research.
Critics says the competing CROs are skewing research in favor of approval in order to win more contracts. The funding up for grabs is enormous. According to a March 24, 2006, MSNBC commentary by Arthur Caplan, director of the Center for Bioethics at the University of Pennsylvania, "Private companies running studies for pharmaceutical and device companies are now a $14 billion industry in the United States alone."
According to John Abramson, a clinical instructor at Harvard Medical School, and author of, "Overdosed America", "When the institutional review boards were created, most medical research was conducted by universities and nonprofit institutions."
"Similarly," Mr Abramson says, "oversight of the safety of human volunteers in most U.S. studies is no longer done by nonprofit IRBs, but by for-profit review companies, hired directly by the for-profit research companies."
In his opinion, he says the system lacks the appropriate checks and balances to protect human volunteers.
In the April 6, 2006 LA Times, Mr Abramson made a shocking revelation when he said, "the FDA recently approved "phase 0 studies" in which human beings can be given minuscule doses of experimental drugs even before animal studies are completed."
A recent case in the UK demonstrates the dangers that could occur in such a study. In March 2006, six otherwise healthy men ended up in a London hospital in critical condition after participating in the trial of a new an anti-inflammatory drug, called TGN1412, to treat conditions involving the immune system, such as leukemia, multiple sclerosis and rheumatoid arthritis, conducted by the US based company, Parexel International Corp, on behalf of the German drug maker TeGenero.
The worst affected of the six men, Mohamed 'Nino' Abdelhady, called the Elephant Man because of the extreme swelling of his head, on April 5th, told the Daily Mail that he is plagued by nightmares.
Still recovering in the hospital at the time, he explained what he remembered. "I started to feel ill," he said, "almost as soon as they had finished injecting me."
"I felt as if I had rocks on my head," he recalled, "and I must have started hallucinating."
"Help me," he told the newspaper that he screamed, "I'm dying."
Ryan Wilson, the most critically ill man, begged doctors to put him to sleep because he was in such agony. His family was warned that his heart, lungs and kidneys failed.
His sister-in-law Jo Brown, recalled the horrific moment when they saw Mr Wilson in intensive care. She told reporters that his head had swollen to nearly three times its normal size, and that his neck was the same or wider than his head and that his skin had turned a dark purple.
Mr Wilson remained in a coma for three weeks, and upon awakening, learned that he may lose parts of his fingers and toes, which had turned black because of his reaction to the drug.
"I'm told it's like frostbite and my fingers will just fall off," he told the UK's News of the World recently.
In addition, Mr Wilson also suffered from heart, liver and kidney failure, septicemia, pneumonia and dry gangrene and is considered very luck to be alive, according to News Target on May 20, 2006.
The Parexel research was at the Phase I stage, where a drug is tested for safety with a small number of people who are given a tiny dose under careful supervision, not to determine whether the drug works, but to check for side effects, according to Q&A Drug trials by BBC News on March 16, 2006.
Experts say the recruitment of subjects for the Parexel trial left much to be desired. The web site that announced the recruitment hardly mentioned the potential risks, but elaborated at great length about the good pay, free food and "plenty of time to read or study or just relax, with digital TV, pool table, video games, DVD player and free Internet access."
Parexel also recruits by placing ads online or in local papers, where critics say, they draw the attention of the young and poor. Once on the books, recruits often get automatic offers. "The offers keep rolling in via text message," Tom de Castella, a former Parexel volunteer said in the March 19, 2006 Times Online. "£650 for three days here, £1,000 for a week there," he said.
Ethicists shown the Parexel consent form, which is supposed to describe the experiment and its risks, told Bloomberg News, "the document didn't sufficiently inform participants of the therapy's possible dangers or properly depict the treatment as a novel drug that can disrupt the body's immune system."
The 13-page form also exploited the subjects' need for money, they said, by threatening to withhold the 2,000 pound ($3,500) payment if the men left the test early.
Highly questionable research recruitment techniques are also occurring in the US. On November 29, 2005, in Texas, CBS News channel 42 reporter, Nanci Wilson, revealed records showing that staff at state mental hospitals in Texas help recruit patients into studies of experimental drugs not approved by the FDA.
At a state hospital in San Antonio, CBS News found 16 beds set aside to allow drug companies to conduct studies on mental patients under the state's care. CBS 42 asked Austin psychiatrist, Deborah Peel, to review some of the records they obtained.
Dr Peel said the situation raised serious questions as to whether this is moral and ethical treatment. "They are essentially turning the state hospital population into research subjects," she noted.
Texas hospital officials claim the mentally ill patients give informed consent by signing a detailed form describing the risks and benefits of participating in the study. But Dr Peel says, "I think there are real questions how informed their consent would be under those situations, because these are not people who have the means to choose to go elsewhere for treatment, and so, there's a powerful element of pressure, of coercion that they have to feel."
"Once again," Dr Peel points out, "we have people who have no means, who are dependent on the state system, and the state system is working hand-in-glove with private corporations."
In many studies, CBS news investigators determined that patients had been taken off drugs that were working and in the new study, some patients were given the experimental drug while others received a placebo.
Critics point out that for patients taking a new drug, there is no guarantee it will work, and the risks and long-term effects are not known. "To take people off medication when they have just been admitted for an inability to function and might have even been a harm to themselves or others, that raises real questions for me," Dr Peel told CBC News.
What's worse, she says, is that patients are not told whether they are taking a placebo or a drug even when they are discharged from the hospital during the study. They could get suicidal, she said, or could harm others.
The FDA has ignored atrocities in research involving mentally ill subjects for years. Back in 1998, a review of the data on atypical antipsychotic drugs submitted to the FDA, obtained with FOIA requests by Robert Whitaker, revealed numerous safety problems for subjects who participated in the trials.
Mr Whitaker found that among 12,176 patients from the US and abroad at the time the data was submitted, there were 88 deaths, including 38 suicides, meaning there was an overall death rate of 1 out of every 138 patients, according to his article in the November 17, 1998 Boston Globe.
The suicide rate in trials was found to be 2 to five times higher than the norm. In the medical literature, Mr Whitaker reported, suicide rates for schizophrenics ranged from two to five deaths per 1,000 per year, while the rate in trials was close to 10 per 1,000.
In addition, he found that for the three approved drugs in the study – Zyprexa, Risperdal, and Seroquel – 60% of the 7,269 patients who received the drugs dropped out before the end of the study, which typically lasted six to 8 weeks.
In the 1990s the prospect of antipsychotic drugs gaining FDA approval, promised a major market for Big Pharma and therefore, drug companies needed to recruit trial subjects quickly. And drug companies were willing to pay top dollars to researchers for each patient recruited.
In the Boston Globe article, Mr Whitaker discusses a criminal case in Georgia that reveals just how far researcher are willing to go to meet recruitment goals.
Dr Richard Borison, chairman of the psychiatry department at the Medical College of Georgia, and Bruce Diamond, a pharmacologist on the school's faculty, were favorites for schizophrenia drugs and demonstrated a knack for rounding up psychotic patients quickly for trials funded Eli Lilly, Janssen, Zeneca, and Novartis.
As faculty members, Borison and Diamond were supposed to get approval for research and payments for trials were supposed to go the school. But according to Georgia authorities, who indicted the duo in early 1997, in 1989 they started having the drug makers send payments directly to them.
They simply opened an office across from the school, hired a commercial service to do ethical reviews of their studies, and placed their staff on the school's payroll but kept all the money for themselves.
As unbelievable as it may seem, the scheme worked for about 7 years. From 1989 to 1996, Borison and Diamond made over $10 million including more than $4 million from schizophrenia drugs, according to the indictment and testimony during an investigation by the Augusta Veterans Affairs Hospital, where Borison was chief of psychiatry.
And these guys were slick. To recruit the mostly male patients, they hired good-looking young women, who testified that they were paid bonuses that ran into the thousands, and one staffer was even given a Honda Accord.
To find their recruits, workers looked for mentally ill patients who were stable and living in the community and offered them $150 to check into the VA so they could be in a study. Patients already in locked wards were offered cigarettes to participate.
Study coordinators, many with no medical training, determined whether a patient belonged in a study. According to an FDA investigation, untrained staff drew blood samples and adjusted doses of the drugs, and Borison and Diamond hardly ever saw the patients at all.
But the two researchers lived high off the hog, according to Georgia authorities. They socked away more than $5 million in cash and securities, spent nearly a half a million on antiques and drove Mercedes-Benz vehicles.
But as the old saying goes, all good things must end. In December, 1997, Diamond pleaded guilty to theft and bribery charges and was fined, $125,000, sentenced to 5 years in prison, and ordered to pay $1.1 million to the college.
Borison pleaded guilty to theft and racketeering charges, was sentenced to 15 years in prison, fined $125,000, and ordered to pay $4.26 million to the college.
To cover all bases, over the years, Big Pharma has also become adept at corrupting the judicial process.
For instance, Dr Bruce Levine, PhD, Clinical Psychologist and author of, World Gone Crazy, tells a story about Eli Lilly corrupting the judicial process in a case that began in 1989 when Joseph Wesbecker opened fire at his former place of employment, killing 8 people and wounding 12 more, before committing suicide, a month after he began taking Prozac. The victims of the shooting sued Eli Lilly, claiming that Prozac had pushed the guy over the edge.
It has long been known that Prozac induces violence in some patients but the FDA never required Lilly to list violence on the drug's label. But as it turns out, five of the 9 members on the 1991 FDA advisory panel investigating the association between Prozac and violence that voted against requiring a warning label for violence, had ties to Big Pharma and two of the members had served as lead investigators for Lilly-funded Prozac studies.
The Wesbecker trial did not take place until 1994, but in the meantime, according to Dr Lavine, "Eli Lilly had been settling many Prozac violence cases behind closed doors."
In fact, he says, more than 150 Prozac lawsuits had been filed by the end of 1994, so "it was looking for a showcase trial that it could win."
A crucial component of the victims' legal strategy in the Wesbecker case was for the jury to hear about Lilly's history of reckless disregard toward consumers, especially about the drug Oraflex, introduced in 1982 but taken off the market 3 months later.
"A US Justice Department investigation linked Oraflex to the deaths of more than 100 patients," Dr Lavine notes, "and concluded that Lilly had misled the FDA."
In the end, Lilly was charged with 25 counts related to mislabeling side effects and pled guilty.
At the Wesbecker trial, Lilly attorneys argued that the Oraflex information would be too prejudicial for the jury to hear and the Judge initially agreed. However, when Lilly attorneys used witnesses to testify about it's superb system of collecting and analyzing side effects, the Judge said that Lilly had opened the door to evidence to the contrary and so the Oraflex information would also be allowed in.
However, to Judge's amazement," Dr Lavine says, "victims' attorneys never presented the Oraflex evidence and Eli Lilly won the case. "
It was later learned that Lilly was successful in corrupting the judicial process in the case by cutting a secret deal with victims' attorneys to pay them and their clients not to introduce the damaging Oraflex evidence.
However, Dr Lavine says, the Judge "smelled a rat" and fought for an investigation, and in 1997, Lilly quietly agreed to the verdict being changed from a victory to "dismissed as settled."
Legal experts are finding ways to expose and punish Big Pharma for conducting fraudulent research that requires no involvement by the nation's compromised regulatory agencies. Barry Turner, Lecturer in Law at Leeds Law School in the UK, is a great fan of the False Claims Act legislation in the US.
As an academic lawyer, he has for a number of years been involved in litigation regarding the activities of the pharmaceutical industry and for the past two years, he has been involved in Qui tam litigation preparation.
"Tying Qui tam into human rights and civil liberties issues is easy," Mr Turner says. "When President Lincoln initiated this law in 1863 it was because Union soldiers were going into battle in shoddy boots and uniforms equipped with guns and ammunition that were third rate," he explains. "All because 'businessmen' saw the war as a gravy train."
"Qui tam," Mr Turner explains, "protects taxpayers and since tax revenue is the lifeblood of any state, any evasion of liability or deliberate defrauding of a taxpayers is an attack on all taxpayers and consequently all citizens."
Qui tam in its long history, he says, has brought to book many crooks who stole from the US taxpayer and is based on the individual citizen being able to blow the whistle for the benefit of fellow citizens and the country.
The more recent Sarbanes-Oxley Act of 2002 (SOX), was enacted in the wake of the Enron and WorldCom scandals, and was designed to restore investor confidence in the nation's financial markets by improving corporate responsibility through changes in corporate governance and accounting practices and by providing whistleblower protection to employees of publicly traded companies who report fraud.
SOX contains a civil and a criminal whistleblower provision. Section 806, creates a civil cause of action for employees who have been subject to retaliation for whistleblowing, and Section 1107, makes it a felony for anyone to knowingly retaliate against or take any action harmful to any person, including interfering with employment, for providing truthful information relating to the commission or possible commission of a federal offense.
According to Mr Turner, SOX is not limited to shareholders of a company. "What needs to be understood," he says, "is that many millions of people who own no stock at all get defrauded in scams all the time."
"Those who pay into pension funds are vulnerable to the financial shenanigans not only of fund managers but of boards of companies," he explains, "and CEO's that fail to police the companies activities or in some cases actively encourage fraud and reckless business practices."
SOX came into being to prevent those financial shenanigans, he says. "The fat cats may lose a small amount of their stake in any scam," he points out, "but the little man as ever stands to lose all."
One of the features of SOX, he says, is the ability to bring an action against those who recklessly and fraudulently deal with stockholders money. Big Pharma, and its handmaiden psychiatry, he notes, is built on fraud.
For example, Mr Turner explains, Ritalin fraud consists of labeling millions of children as basket cases based on fraudulent research and a consensus of the vested interest.
"SSRI fraud," he advises, "extends depression into the world of normal human experience to ever-extend the peddling of the often useless and frequently dangerous treatments."
In other instances, he says, many poor and elderly people are starved of life saving drugs because the budgets of Medicare and Medicaid are bled dry by claims from drug companies for 'me too' drugs that in many cases are superfluous.
"Even where there is some justification for the use of these drugs," he explains, "there is a drive to constantly increase the dose above the minimum effective one because a 'minimum effective dose' to the drug company means minimum effective profit."
"Where money is diverted from real healthcare provisions, to a profit greedy industry that manufactures an illness to fit the drug," he notes, "rather than provide drugs for real illnesses, then the most fundamental of constitutional rights 'Life, Liberty and the Pursuit of Happiness' is most at risk."
Every unnecessary dose of Ritalin, Prozac, Paxil, and other psychiatric drugs prescribed and paid for with US tax dollars, he says, deprives patients dependant on state healthcare programs of drugs they need for cancer, diabetes, heart disease and other serious conditions.
In addition, Mr Turner points out that, "the marketing of these drugs and the ever expanding definition of psychiatric disorder that is part of this marketing strategy labels, discriminates against, and stigmatizes hundreds of thousands of American Citizens."
"It is indeed a dramatic irony," he says, "that in very many of these cases the US taxpayer gets to fund an industry that acts in a manner so alien to the American Constitutional ideals."
For purposes of the litigation, "knowingly" is defined as: (1) Actual knowledge of the false information; (2) Acts in deliberate ignorance of the truth or falsity of the information; or (3) Acts in reckless disregard of the truth or falsity of the information.
Therefore, according to Mr Turner, "inducing people to invest in companies that engage in illegal and reckless activity is a violation of SOX."
"Inducing people to take vast amounts of drugs that are known to be harmful and deliberately hiding the known dangers is a violation of SOX," he contends.
"One day this edifice will come tumbling down," he says, "and what will the investors in Big Pharma say then?"
In light of the Vioxx disaster, Mr Turner says, we should perhaps ask people who invested in Merck.
"Those at the top of this company," he notes, "gambled with the lives of patients and the money of stockholders in equal bad faith when they engaged in fraudulent and dishonest behavior that allowed a dangerous drug to be marketed."
"Those who today peddle drugs for fictitious illnesses and push dangerous and useless medications on the children," he warns, "in our societies are doing just this."
Merck acted with reckless disregard for the truth because it had prior knowledge of the adverse effects of Vioxx. The same goes for Eli Lilly and its prior knowledge of the lack of efficacy of Prozac and GlaxoSmithKline's knowledge of Paxil's suicide ideation
While suppressing negative studies, these companies placed drugs on the market that were known to be faulty in one way or another. All of these drugs have cost taxpayers dearly, not to mention the personal suffering they have inflicted in other ways.
In considering other acts of fraud, Mr Turner looked at the Pharma backed charities that are based on fraudulent research to see what Federal laws they may be violating.
"Since a number of imaginative illnesses are based on this fabricated research and since a number of charities are based on the 'imaginative illnesses' that arose out of the imaginative research," he says, "its just a matter of connecting the dots."
Because charities receive tax breaks, he says, fraudulent charities defraud US taxpayers.
"The fraud in this industry is not divided into that which injures by over drugging and that which cheats taxpayers and stockholders out of their money," he explains. "They are two sides of the same counterfeit coin."
Mr Turner says we must tackle them together, and that lawyers in the US should be actively seeking clients who have lost money by these frauds and getting the matter before the Security and Exchange Commission now.
Information for injured parties can be found at Lawyers and Settlements
http://www.lawyersandsettlements.com/articles/Pharma.html
Previous articleMissing the Point and the Target
Next article'Escalation', 'retaliation' and BBC double standards in Gaza
Evelyn Pringle is a columnist for Independent Media TV and an investigative journalist focused on exposing corruption. She contributed this article to Media Monitors Network (MMN).


text:
cask 'locko' do
  version :latest
  sha256 :no_check

  url 'http://download.binarynights.com/Locko.zip'
  appcast 'http://update.binarynights.com/locko/sparkle-update.xml',
          :sha256 => '109cd2e84b31bafcc00c84f5fbb8a3dc27653c1aaeba983b9f4cd5ef41258afd'
  name 'Locko'
  homepage 'http://www.binarynights.com/'
  license :commercial

  app 'Locko.app'
end

redpajama_set_name: RedPajamaGithub


• A sensor is required. The Wallmount Controller uses a standard T/C receptacle. To include a Sensor, please select the drop-down "Sensor" box above.
The WM-15 Limit Controller is a Single Zone PID Temperature Controller, with an additional, independent "push to reset" Limit Control with mechanical relay switching.
The Limit control provides protection against any process malfunction, turning off all heating power if Limit is exceeded. The WallMount unit has rugged simplicity to get you results without learning a custom programming language. This controller is ideal for laboratory or industrial heating control requirements.
Standard WM-15 Controllers offer a maximum load capacity of 15 amps at 120 or 240VAC. Customized options and configurations are available. "Click" the CUSTOMIZED button or contact the factory for more functionality.


text:
Il pallor mortis (dal latino "pallore cadaverico") è un pallore post mortem che sopraggiunge tra i 15 ed i 120 minuti dopo il decesso a causa della mancanza di circolazione capillare attraverso la pelle.

Il sangue si deposita per gravità nelle parti inferiori del corpo causando il livor mortis.
Il pallore si presenta così rapidamente dopo la morte che non ha alcuna utilità nello stabilire l'ora del decesso, a meno che questo non sia avvenuto nella prima mezz'ora antecedente il ritrovamento del corpo.

Bibliografia
 Gian Aristide Norelli, Claudio Buccelli, Vittorio Fineschi. Medicina legale e delle assicurazioni, Piccin-Nuova Libraria, 2009

Tanatologia

redpajama_set_name: RedPajamaWikipedia


text:
Q: Count number of commas in a list With the following command the tokens can be counted in a list. How can I count only the number of commas in the list?
\documentclass{article}
\usepackage{xfp}

\begin{document}
\ExplSyntaxOn
\NewDocumentCommand{\CountComma}{m}{%
\tl_count:n {#1}
}
\ExplSyntaxOff

\CountComma{1/!/?,2/1/0,3+2/1*2,4/0,5/1/0,6/0,A/B/1,8/0,9/0}

\end{document}

A: This is only a solution for the case that commas do not follow each other without element between or do not occur inside {} pairs:
\clist_count:n counts the number of elements in a comma separated list, however, {1,2} would give 2 instead of 1, so wrap \int_eval:n{\clist_count:n {#1} -1} around this.
Using the hint by egreg: \int_max:nn {\clist_count:n {#1} -1}{0} is shorter
Of course the \CountComma macro should be expandable, so use \NewExpandableDocumentCommand.
\documentclass{article}
\usepackage{xfp}

\ExplSyntaxOn
\NewExpandableDocumentCommand{\CountComma}{m}{% Should be expandable!
    \int_max:nn { \clist_count:n {#1}-1 } {0}
}
\ExplSyntaxOff

\begin{document}

\CountComma{1/!/?,2/1/0,3+2/1*2,4/0,5/1/0,6/0,A/B/1,8/0,9/0}

\CountComma{1,2}

\CountComma{4}

\edef\foo{\CountComma{1,2,3}}

Foo is \foo

\end{document}

redpajama_set_name: RedPajamaStackExchange


text:
Pay Per Head
Pay Per Head Services
Pay Per Head Sites
Pay Per Head Bookies
Pay Per Head Sportsbook Services
Bookie Software
Call now! 1-866-Call-IDS (1-866-225-5437)
Category: Live Betting Sports
Try our easy-to-navigate platform that can be used with ease by both the first-time user and the seasoned live betting sports devotee. If you are interested in our in-play live betting solutions for your customers, or if you just want to see it for yourself, give us a call at 1-866-CALL-IDS (1-866-225-5437) or send us an email.
NHL Predictions: NHL Playoff Hopefuls
We're almost there! The excitement for NHL fans when their team gets to play for hockey glory in the NHL playoffs is something truly amazing. Let's see how our NHL predictions are coming along with who's ready to go to the NHL finals and the vie for the Stanley Cup. NHL fans are a breed…
By: IDSCA Staff | March 14, 2015
in Live Betting Sports
RB LeSean McCoy is set to join the Bills
RB LeSean McCoy's agent said that the player and the Bills agreed to a deal of $40m which is set to run for five years, and a guaranteed $26.5 million is included in the contract. White label sportsbooks now see a much stronger team for next season, as the player is seen as a force…
By: IDSCA Staff | March 8, 2015
Bafetimbi Gomis collapses in game against Tottenham
Just a few minutes passed since the start of the Premiere League match between Swansea and Tottenham when Bafetimbi Gomis fell on the ground. Fans and white label sportsbooks who saw what happened on Wednesday were very worried, especially since it's not the first time that the player collapses. Gomis fell on the ground while…
Colts GM Ryan Grigson warned the NFL about deflated footballs
On Thursday, Colts GM Ryan Grigson publicly admitted for the very first time that the team talked to the league about their worries regarding the balls used by the Patriots the week before the championship game of the AFC. NFL fans and live betting services continue to be surprised by the emerging events of this…
By: IDSCA Staff | February 19, 2015
Carmelo Anthony set to receive season-ending knee surgery
On Wednesday, the Knicks announced that Carmelo Anthony is set to receive surgery on his lefty knee, something that will see his season come to an end, and bookmaker software services fear that the team is in even more trouble now. Phil Jackson, team president, said that a timetable for the player's recovery will not…
By: Jose Barquero | February 18, 2015
Charles Barkley said that he once played drunk
Once upon a time, former NBA great and current TNT basketball analyst Charles Barkley thought that he was going to play for the Lakers, and live betting services remember being very surprised when they learned that he actually played after he prematurely celebrated the news. Back in 1992, it seemed that the 76ers and Lakers…
Amar'e Stoudemire was waived by the Knicks
On Monday, Amar'e Stoudemire was waived by the Knicks, putting an end to the injury-ridden time that the player spent with the team. Live betting services now wonder what move the player will make next, and the fans can't wait to find out. Sources reported that on Sunday, both parties agreed on a buyout of…
Kevin Durant spoke his mind with the media
On Saturday, Kevin Durant was very blunt when he spoke with reporters in New York on Saturday during the All-Star Weekend, surprising many fans and bookmaker software services with what he had to say. "You guys really don't know s—," said Durant. The player made his statement when he was answering a question about the…
Paul George could return to action in the middle of March
Sources reported that the Pacers' Paul George could return to action on the 14th of March in a game against the Celtics, which is sooner than was originally planned. Live betting services see many optimistic fans, and they're confident that the team will get a massive boost when the world famous shooting guard returns. The…
Will Peyton Manning play again for the Broncos next season?
It was reported that Peyton Manning is looking to play again in 2015, but this would ultimately be up to the Broncos. However, NFL fans know what an important part of the team he is, and live betting services know that many of them don't want to see the QB leave the Broncos just yet….
Seahawks GM said that talks about Wilson's contract have started
Seahawks GM John Schneider said that talks started with QB Russell Wilson regarding his contact with the team, and live betting services would really like to see what will come out of these discussions. The GM said that the player "gets it and wants to win". He also mentioned the Seahawks wanting to get the…
Brett Favre to enter the Packers' Hall of Fame
This year, Green Bay's one and only Brett Favre will go back to Lambeau Field so he can be welcomed into the team's Hall of Fame and have the Packers retire his No. 4 jersey, and live betting services saw that on Monday, the QB made an announcement about his plans on his website. The…
By: IDSCA Staff | February 9, 2015
Chris Paul fined after criticizing referee
Chris Paul, point guard for the Clippers who's a big favorite with online bookmakers around the world, was given a $25,000 fine after he publicly criticized Lauren Holtkamp, a first-year referee who earlier in the week gave the player a technical foul. On Saturday, the fine was announced by the league – two days after…
By: Jose Barquero | February 7, 2015
LeBron James would do anything he can to help the Cavaliers
The Cavaliers impressed fans and online bookmakers by winning 11 games in a row – a best in the NBA – and LeBron James said that he's willing to do anything necessary for them to continue being successful, even if he has to leave the bench and play again. "It's all about the team and…
The NFL decided to not fine Marshawn Lynch
An NFL official said that Seahawks RB Marshawn Lynch fulfilled his requirement to show up at Super Bowl media sessions, and he won't be given a fine. Many fans and live betting services were concerned about the player having even more problems, but were glad to see that this wasn't the case. There are also…
Get online bookmaking services now and start growing your business. Get in touch with one of our contact center specialists who is waiting to answer your questions and set you up with a demo or free trial today. Call 1-866-CALL-IDS (1-866-225-5437) or fill out the contact form for a quick online response.
Bookmaker Sports News
IDSca White Label Advantages
© 2021 IDSCA Pay Per Head. All Rights Reserved. | Price per Head | IDS, the Pioneer in Pay per Head, PPH, Bookmaker Services and online bookie software in Costa Rica since 1997 Offering White Label Service for Sportsbooks, Live Mobile Cloud Betting and Online Casino Support with Reliable, State of the art Servers. Terms & Conditions | Privacy Policy | Sitemap

redpajama_set_name: RedPajamaCommonCrawl


Because Plains Regional Medical Center is owned by the communities we serve, we are governed and guided by community leaders who serve on our Community Board of Trustees. Our not-for-profit structure and community-based governance ensure healthcare resources are adapted to best meet the community's healthcare needs.
These fellow New Mexicans willingly donate their time, energy, and expertise to improving the health of patients, members, and the communities we serve.
Lonnie Leslie serves as chair of the Plains Regional Medical Center Community Board of Trustees. He also previously served as chair of the Quality committee.
Mr. Leslie is a retired school district administrator who spent 33 years with Clovis Municipal Schools. He received both his bachelor's degree and master's degree from Eastern New Mexico University.
Mr. Leslie is chairman of the Local Growth Management Organization planning for growth at Cannon Air Force Base and is also the chairman of the Curry County DWI Task Force and a member of the Clovis Schools Foundation board of directors.
He is the past president of the Clovis Rotary Club and was named by the Clovis Chamber of Commerce as the Citizen of the Year in 2008. He has also been honored with awards for New Mexico Administrator of the Year, Clovis Rotary Club Rotarian of the Year, the United Way Golden Heart Award, and the Eastern New Mexico University Educator Hall of Honor.
Chris Bryant is a member of the Plains Regional Medical Center Community Board of Trustees.
Mr. Bryant owns the Foxy Drive-In restaurant and represents District 4 ion the Clovis City Commission, where he is chairman of the water policy committee. He also serves on the Eastern New Mexico Water Utility Authority.
Mr. Bryant represents the City of Clovis on the Civil Aviation board, the Chamber of Commerce board and the Clovis/Curry County Chamber of Commerce Railroad committee. He also serves on the board of directors for the New Mexico Restaurant Association.
Derek Cockrell is a member of the Plains Regional Medical Center Community Board of Trustees.
Mr. Cockrell is the owner and president of Contemporary Benefits, LLC, an employee benefits and financial planning design and administration firm in Clovis. He has worked in the financial planning and employee benefit industries since 1996. Mr. Cockrell has also served on the Plains Regional Medical Center governance and finance committees.
Mr. Cockrell received his bachelor's degree in business administration and human resource management from Eastern New Mexico University in 1996. He is a past president of the Clovis Rotary Club, the United Way of Eastern New Mexico, and the San Vincente Homeowner's Association and has served as the finance committee chair for the Boy Scouts, Conquistador Council. He currently sits on the executive committee and is a board member of the Curry County Chamber of Commerce. Mr. Cockrell is also active in his church and has served in various capacities over the last two decades.
Paul Ellis is a member of the Plains Regional Medical Center Community Board of Trustees.
Mr. Ellis offers more than 40 years of experience in banking and finance. Mr. Ellis has served as the senior vice president and chief lending officer at American Heritage Bank for more than 12 years, and was the executive vice president and chief lending officer at First Savings Bank of Clovis for more than 16 years.
Mr. Ellis is a member of the Clovis Rotary Club, Clovis Committee of 50, Clovis Elks Club, and the finance committee of Sacred Heart Catholic Church. He also serves as a board member for the Clovis Industrial Development Corporation and the Clovis Chamber of Commerce.
Mr. Ellis received his bachelor's degree at Southwestern State University in Weatherford, Oklahoma. He completed specialized training in finance and banking operations at the Graduate School of Banking at Colorado in Boulder.
Priscilla Hernandez is a member of the Plains Regional Medical Center Community Board of Trustees.
Ms. Hernandez works as the assistant superintendent of curriculum, instruction and assessment for Portales Municipal Schools. She is a 34 year veteran of public education and has worked in area school districts including Clovis, Portales and Muleshoe, Texas.
Ms. Hernandez is strongly committed to team building while leading others in highly demanding situations. She also is effective in using data in decision making for both short and long range planning.
Ms. Hernandez received two post-secondary degrees and one certificate, all from Eastern New Mexico University. She received her bachelor's degree in education in 1975, her master's degree in education in 1979 and a public administration certificate in 1986.
Ms. Hernandez was recognized by Who's Who Among Professional Women in 2007 and 2008, Who's Who in American Education in 1996 and by Outstanding Young Women in 1985.
Albert M. Kwan, MD, FACS is a member of the Plains Regional Medical Center Community Board of Trustees.
Dr. Kwan is the president of the medical staff at Plains Regional Medical Center. Dr. Kwan has been practicing medicine in Clovis since 1993. He has served as a member of the Medical Executive Committee for the past 14 years, including serving as chair of surgery and vice president of the committee.
Dr. Kwan earned his medical degree at the University of New Mexico School of Medicine in 1983 and completed his surgical residency at Texas Tech University. He served in the US Air Force as a general surgeon and flight surgeon from 1988 to 1993 and as chief of surgery in three US Air Force hospitals, including a mobile hospital during Operation Desert Storm.
Dr. Kwan is a past president of the New Mexico Medical Society and is currently the governor of the New Mexico Chapter of the American College of Surgeons. Dr. Kwan is also a member of the Alpha Omega Alpha Medical Honor Society.
Rev. Anthony Mahan is a member of the Plains Regional Medical Center Community Board of Trustees.
Rev. Mahan retired from his role as chief master sergeant after 30 years of service in the US Air Force and is currently the site manager for Melrose Air Force Range at Cannon Air Force Base. Along with his associate pastor duties at Triangle Baptist Church, Rev. Mahan serves as president of the Ministerial Fellowship of Clovis, as board member of the Clovis Chamber of Commerce, as member of the advisory committee for the Governor's Office of African American Affairs and as the vice president of the Clovis chapter of the NAACP.
Rev. Mahan received his bachelor's degree from Embry-Riddle Aeronautical University in Daytona Beach, Florida.
Ben McDaniel is a member of the Plains Regional Medical Center Community Board of Trustees.
Mr. McDaniel has been a partner in and operated McDaniel's Furniture for the last 10 years.
Mr. McDaniel currently serves as the chairman of the Curry County Commission. He is also on the board of directors of the Clovis Industrial Development Corporation and the Clovis Municipal Schools Foundation. Mr. McDaniel is a member of the Median Beautification Committee and the Curry County Investment Committee. In the past, he has served as a member of the City of Clovis Beautification Committee, and the Revenue Review Committee.
Mr. McDaniel graduated from Clovis High School in 1999. He went on to West Texas A&M University and Wayland Baptist University to receive his bachelor's degree in business administration.
Joyce Pollard is a member of the Plains Regional Medical Center Community Board of Trustees.
Ms. Pollard has worked with the Clovis Municipal Schools for 34 years, and won a Lifetime Achievement Award from the City of Clovis. Most of her teaching experience was in kindergarten, first and second grades. She taught at Cameo Elementary, Lincoln-Jackson Elementary, James Bickley Elementary and Parkview Elementary. She retired in 2001 and now works as a substitute teacher.
Ms. Pollard has served as the president of the Black Advisory Council at Clovis Community College, and she has been a member of the board of directors for the Clovis Community College Foundation. As president of the Martin Luther King, Jr. Commission, she was instrumental in the naming of a street in honor of Dr. King.
She earned a bachelor's degree in education in 1980 and a master's degree in elementary education in 1983, both from Eastern New Mexico University.
Larry Roberts is a member of the Plains Regional Medical Center Community Board of Trustees.
Mr. Roberts has extensive experience and involvement in the agriculture community, including serving as a farm manager and certified crop advisor. Over the past 40 years, Mr. Roberts has served on various committees through his church, functions in the community and with the Clovis Public School system.
Mr. Roberts received his bachelor's degree in agriculture business and economics from West Texas State University in Canyon.
Richard Smith is a member of the Plains Regional Medical Center Community Board of Trustees and is the chief hospital executive of Plains Regional Medical Center and Dr. Dan C. Memorial Hospital in Tucumcari, NM.
Mr. Smith has more than 35 years of leadership experience in healthcare administration. Mr. Smith has served as a chief financial officer, multiple hospital controller and chief executive officer, as well as a county manager. He owned his own medical consulting company for 15 years, specializing in strategic planning. Mr. Smith received his bachelor's degree in business administration from the University of Tennessee in Knoxville. He is a certified public accountant and chartered global management accountant.


As more and more data becomes accessible online it becomes easier for everyone, including prying neighbors to access it with ease.
We found this site http://www.zillow.com/ that allows users to access property values for homes (including increases and declines in value), satellite images and even more interesting details. It is a great service with a lot of useful potential but like any information service it could be abused. The data is based on county-wide data, so it is publicly accessible but the online service makes it very easy to do from home. With Zillow, property values, satellite images, average mortgage rates, and home appraisals.
Is too much information online a bad thing? It all depends on how it is used. Try it for yourself and see and rest assured there will be a number of similiar services crop up. Of course, one can easily use the free Google Earth to inspect properties in incredible details- located in the Google Pack.


Click the button below to add the Chinese PIG Zodiac SCORPIO heart Sterling Silver charm to your wish list.
If you make friends with a pig you can be sure that youfound a friend for life. He or she is gonna stick with you through thickand thin. They bond really easy and have very deep and devoted relationships.They are mostly gallant, old-fashioned and chivalrous to the people theymeet. The pig is the sign of honesty good fortitude and simplicity. Theoriginal "Mr. Nice Guy", appears outwardly rough, jovial andquick tempered but if you scratch the surface once you will see that onthe inside beats a heart of gold. Courageous and strong a pig person willattach himself to an imposed task with all his tremendous inner strengthseeing any problem through that comes up along the way. Fights an differenceswith others they almost don't know unless the other person doesn't givehim another choice but he will always be straight forward and will neversolve his problems with others behind their back. It is said that thepig is one of the most natural signs in the cycle you can come across.Not much of a "Party-Animal" he enjoys quietness and the trivialities,but never the less the best things, of life. With an abundance of goodfortune and longevity the pig will experience a life full of serenityand riches.
The pendant reflectsbeautiful in the light!!! So many designs andapperance makes this pendant a must have!
You are Bidding on an extremley rare hard to find sterling silver detailed Chinese Horoscope PIG charm. You can the entire internet and chances are you won't get your hands on this incredible pendant. This item isn't even available in stores. This pendant isn't like most other pendants! It is very detailed and sterling silver. This pendant starts at cost price. Be the proud owner of this beyond detailed pendant at the cheapest price in the world!. Who know's when you'll be able to get your hands on one of these again.
mint condition (FLAWLESS!) Pendant is as shown in the picture. This pendantretails for $55.99 minimum because of it's detailed artistic appearanceand rareness.
Don't want to wait for this auctionto end?


Tracks: Those students choosing to pursue the option in CEP may choose a thesis, professional paper, or non-thesis degree track (thesis and prof. paper tracks must include typically 3-6 credits of thesis hours that are in addition to the 33 credit minimum - please see above OVERVIEW).
For electives that pertain to Community Planning, Environmental Planning, GIScience, Native American Communities, Policy, and others, see Catalog listings for Anthropology, Communication Studies, Environmental Studies, Forestry, Geography, Law, Native American Studies, Political Science, and other relevant departments and programs.
Please see the 'General Degree Requirements' for courses previously taken.


text:
Q: Get HTML display area (viewport) offset to 0/0 and zoom of IE window using .NET/C# and SHDocVw.InternetExplorer THIS IS NOT A HTML / JAVASCRIPT / CSS question!
Check out these images:

I need to get the HTML display area (aka viewport) offset to the 0/0 of the IE window.

*

*I am targeting Microsoft Internet Explorer 11.

*I am using C# with SHDocVw.InternetExplorer library to access/control the IE.

What I actually want to do is to trigger double-click events

*

*similar to IHTMLElement.click(), just a doubleClick()

*calling IHTMLElement.click() multiple times does not work

I tried to solve it WITHOUT actually clicking:

*

*How to make SHDocVw.InternetExplorer fire events that get caught with JS addEventListener?

*but that has not received any answers yet

So right now I'm controlling the mouse to trigger certain events, calling       [DllImport("user32.dll")] public static extern bool GetCursorPos(out PointInter lpPoint); and the like to get and set the mouse cursor and to simulate double-clicks on certain elements.
For the mouse navigation I already take into consideration

*

*the OS's desktop zoom/scale setting

*the IE window Left and Top properties

*the location of the IHTMLElement(3).getClientBoundingRect, i.e. the position of the element I wanna trigger

This all works perfectly fine when the IE configuration is the same. My assumptions:

*

*same HTML viewport offset (same toolbars, menus etc)

*HTML viewport scaling 100% (no page zooming)

But those two factors are dynamic, so I have to account for them in some way.
So what I need is:

*

*The HTML viewport's vertical offset (in both screenshots it's 106 pixels)

*The HTML viewport's horizontal offset (in first its 1, in second it's 291)

*The HTML viewport's zoom factor (in both screenshots 100%)

I have tried accessing multiple elements in the ShDocVw.InternetExplorer object, but I either have the wrong interface casts or it does not expose this information willingly, because I could not find it yet.
From a delve into the google world I also came up empty, so no (obvious) answers there either.
So does any one of you know how to deal with this problem? Some obscure COM/OLE incantations and rituals that could guide the mouse cursor on its way?
EDIT:
Dirty solution: I could display some homemade HTML/JS page first, that detects my simulated mouse movement and dump that information into some (invisible) div, then read that data in C#.
Though this is a solution, it's quite ugly and not useful for taking into account layout/display changes that might occur during later runtime, if user changes zooms while the app is working.


Like the recent Zeitgeist post on the Dalston Roof Park, Berlin's Prinzessinengarten"the Princess' Garden is yet another example of green entrepreneurs cultivating a community through urban gardening. Located next to the unappealing facades of Moritzplatz, a once zoned motorway in Berlin Kreuzberg, two entrepreneurs turned a once barren 6,000 meters into a lush sustainable garden.
Calling their company "Nomadic Green," Robert Shaw and Marco Clausen created a sustainable meeting and learning space through gardening. The agricultural space lets neighbors, school kids and curious passersby observe and even help with the growing of potatoes, herbs and vegetables. Like Dalston, visitors can visit a small cafe within the garden that is supplied with fresh offerings straight from the bed.
Shaw and Clausen worked to make the outdoor area an agricultural learning center for the neighborhood with community workshops that spread the art of inner city gardening and offer tutorials on organic food production, biodiversity and climate protection, making Prinzessinnengarten an invaluable green space in a mostly urban area.
The garden utilizes a number of flexible concepts that enhance portability and sustainability: tomatoes flourish in growing sacks, peas grow in former breadboxes and basil resides in recycled milk cartons. Much like the green space in Dalston, Prinzessinnengarten relies on donations from local business and sponsorship of garden beds. Last but not least, all produce is for sale. A board displays the daily vegetables and herbs that are ready for harvesting.
The garden will remain open until the end of fall.


text:
The Precarious Nature of Running a Digital Publication in 2019
SitePointTeam July 2, 2019, 6:11am #1
Originally published at:	https://www.sitepoint.com/running-an-online-publication-in-2019/
This article was created in partnership with Proper Media. Thank you for supporting the partners who make SitePoint possible.
Recently, there have been countless articles and think pieces written about the decline of publishing. These articles often illustrate how difficult it is for publishers to monetize what they do to eke out a sustainable business model.
In reality, advertising revenue is down for independent publishers across the board. More people are using advanced ad blocking software, which is impacting the number of ads publishers can show. Plus there are two giant elephants in the room — Google and Facebook. These two entities combined account for almost 60% of the total advertising spend online. This duopoly uses third-party publisher content to bring in advertising revenue, but leaves very little revenue for the publishers themselves. For better or worse, they also have the scale to very effectively monetise their user base, which a smaller publisher just can't compete with. Facebook, for example, has an average CPM of around $8 compared to an average CPM of $1 for third-party publishers. As the online advertising world evolves, publishers will face new obstacles to monetize their websites.
[caption id="attachment_172667" align="alignnone" width="470"]
1561438624emarketing.png470×583
Source: eMarketer[/caption]
To overcome these difficulties, publishers have all tried different ways to generate revenue in this new landscape; the New York Times and many others have tried to sell premium subscriptions to their users by hiding their content behind paywalls. Another example of subscription-based revenue is Apple News+, which is an attempt to distribute some subscription revenue to publishers, albeit after Apple takes its healthy cut. However, consumers are still very unlikely to pay for content online. A study by Reuters Institute and Oxford University recently found that only 13% of people in the US pay for an ongoing news solution.
Paywalls have worked effectively for some publishers like the New York Times, where they have seen year-on-year revenue growth for their premium subscription product. But this is just not feasible for a lot of others, who are seeing a backlash from users to this system. In addition to being ineffective for many publishers, paywalls are inherently at odds with a publisher's goals. Publishers want to produce content that educates and informs the largest number of people, which is the opposite of how a paywall operates. With these constraints around subscription-based website monetization, traditional display advertising has remained a large part of overall publisher revenue, including ours.
The simple fact is advertising has always been integral to an online publisher like us—it is how we here at SitePoint keep everything running and pay for our writers to produce interesting content that you come to read. We, like all other businesses, have to generate revenue. We've faced the same challenges over the years and the same struggle to strike a balance between generating revenue with advertising (in order to continue to produce a plethora of free, educational content), while creating a user experience that allows our readers to digest and enjoy that content without annoyance. We admittedly do not always get this balance right.
Currently, we're teamed up with Proper Media as our programmatic revenue partner, in hopes of finding that balance. The way it works is that we leverage Proper's header bidding solution to monetize the ad slots on our article pages. Working with Proper allows us to get the highest CPMs by creating competition for our inventory across all the top advertising demand available (e.g. Amazon's A9, Google Adx, and AOL's OATH). Additionally, they take care of the direct demand for ad sales. Gone are the days when advertisers bought large advertising blocks from individual publishers — nowadays, it is all run programmatically.
In short, Proper handles the monetization so we can focus on producing great content. They ensure that our ad revenue is as high as possible. They have continuous data-driven optimization and granular real-time reporting which ensure that we are always getting the best yield for our ad units. They also handle all of the receivables and deliver a consolidated payment that is on faster terms than all major exchanges, which really helps the cash flow of a small publisher like us.
m_hutley July 2, 2019, 12:15pm #2
#DefinitelyNotAnAd
ukoutreachexpert July 4, 2019, 4:37am #3
what is the reason that only 13% of the people pay for subscription while there are so many people in the digital world.
SitePointTeam closed October 16, 2019, 1:16pm #5


text:
"Manchester by the Sea": A stunning turn by Casey Affleck
by By Tirdad Derakhshani, Staff Writer
Writer-director Kenneth Lonergan (You Can Count on Me, Margaret) proves once again he's one of our finest dramatists with his third movie, Manchester by the Sea, an achingly graceful, heartfelt, working-class story about loss, grief, and family obligations.
At turns elegiac, absurdist, and gently satirical, Lonergan's drama is a deeply affecting chamber piece that features an outstanding performance by Casey Affleck (Gone Baby Gone, Ocean's Eleven) as a Boston janitor and apartment building super who is forced by his brother's death to return to his North Shore hometown.
If early award-season buzz is any indication, the film may earn Affleck his second Oscar nomination. (The first was for his mind-blowing turn in the 2007 Western The Assassination of Jesse James by the Coward Robert Ford.)
Affleck plays Lee Chandler, a morose, lost soul given to heavy drinking and fistfights who returns to the tiny fishing village of Manchester-by-the-Sea, Mass., to attend to the affairs of his brother, Joe, who has died in his early 40s, leaving behind a teenage son, Patrick (Lucas Hedges).
Lee's return isn't exactly a happy one: He was all but banished a few years earlier after a soul-crushing turn of events. Michelle Williams has a touching appearance as Lee's ex-wife, whose anger mellowed long ago into a melancholy, semi-bitter kind of longing.
Lonergan uses the film's first half to paint a landscape of loss that's almost overwhelming to behold. Joe, who was immensely popular in the community, is mourned by the whole town, but most intensely by Patrick and Lee.
Both guys were raised to fear the free expression of emotions as a sign of weakness, so instead of talking, instead of mourning together, they bicker and fight.
Things become even more strained when Lee learns that Joe named him as Patrick's legal guardian and left explicit instructions that Lee move back to town.
Lonergan, 54, who has two previous Oscar nominations for screenwriting for You Can Count on Me and Martin Scorsese's Gangs of New York, depicts grief with great specificity and great power with judicious use of flashbacks.
Despite its heavy tone, there's nothing morose about Manchester by the Sea. True to the rhythms of real life, the film opens up periodically with moments of joy and comedy reflecting Lee and Patrick's growing friendship and their oddball Odd Couple partnership. When Patrick tries to set up his uncle with a friend's mom (Heather Burns), the two adults sit across from each other, stiff and silent as statues.
Months pass, and life gets a little easier for Lee and Patrick. But they remain enmeshed in the painful, arduous reality of their lives.
There are no Hallmark moments here, no easy resolutions or magical reconciliations.
Manchester by the Sea attains true greatness as drama because it cleaves so stubbornly and so faithfully to reality. And in the real world, the deep trauma and the lingering grief experienced by Lee and Patrick don't just disappear. They are not overcome or beaten. They are simply borne. What Loneregan's film suggests is how one can bear them with a measure of grace.
Published Nov. 22, 2016
By Tirdad Derakhshani, Staff Writer


Brandon, MB. - The National Hockey League's Carolina Hurricanes have announced the signing of Brandon Wheat Kings' captain Stelio Mattheos to a three year entry level contract that will begin next season.
The club also announced that the 19-year old Winnipeg product will begin his professional career with the Charlotte Checkers under an amateur tryout contract for the balance of the 2018-19 campaign.
The 19-year-old Mattheos was the WHL's fourth-leading goal scorer last season, scoring 44 goals while serving as the captain of the Brandon Wheat Kings. A third-round pick in the 2018 NHL Draft, Mattheos finished his career in junior hockey in spectacular fashion, posting 96 points to lead the Wheat Kings in scoring this season and following up on a 90-point performance in the year following his draft. He was the only player in the WHL to score 40 or more goals in each of the past two seasons.
"Stelio is a highly skilled center coming off back to back 90-point seasons in Brandon," says 'Canes' General Manager Don Waddell. "He's shown great ability as a goal scorer and we look forward to the next steps in his development."
With Carolina, he joins Foxwarren product Morgan geekie with the Checkers.
Mattheos says that his four years in Brandon was valuable.
"When I showed up I was just probably a kid," he told Perry Bergson of the Brandon Sun. "My knowledge of the game and my skill level has gone up tremendously since I showed up in Brandon. I can't thank everyone enough in Brandon for helping me to develop."
Mattheos capped off his 2018-19 WHL season this past weekend by taking home four trophies at the Wheat Kings annual awards day - Most Valuable Player, Turk Broda Top Manitoba Born, Scoring and the Canad Inns 3-Star Award.


Discussion in 'General Security' started by Steve159, Mar 30, 2008.
I need to get into my firewall config, i know it sounds like a stupid question but heres the thing, I already check and i don't have the default windows firewall enabled, I'm using Norton's Anti-virus but not Norton's Internet Security. I cant find a option that allows me to allow/block programs in my firewall. I used the security center in the control panel to see what firewalls i have in use and it says Norton's Anti-virus and Norton's Internet Security (even though i don't remember installing the internert security). So my question is how do i access firewall controls through Norton's Antivirus?
Hi Steve, Maybe I don't fully understand what you're trying to do but if you clik "start">control panel>then dbl clik Win firewall, you can turn it on or off, set exceptions & other stuff on the advanced tabs. Ahhhh but then I recall that Norton won't let you do that!! Maybe that's what you're talking about.There should be a work-around but I don't have Norton any more so I don't know.
In the Security Center in the control panel it says that i have two firewalls active, Norton's Antivirus and Norton's Internet Security.
But when I open Norton's i cant find the firewall control option to allow or block programs.
it replaces windows firewall - as it is a firewall of sorts.
not sure why you are seeing NIS. maybe do a find or look in add/remove.


This sedan with automatic transmission has excellent technical and design indicators - it will feel comfortable for a beginner driver, as well as the responsible father of the family (5 seats). The car can accelerate to 221 km / h, while remaining quite economical: the consumption of diesel fuel in the city will be only 6.9 liters. The country cycle - 6.1, mixed - 6.0, respectively.


text:
package org.apache.camel.component.paho;

import java.util.concurrent.CountDownLatch;
import java.util.concurrent.TimeUnit;

import org.apache.activemq.broker.BrokerService;
import org.apache.camel.CamelContext;
import org.apache.camel.EndpointInject;
import org.apache.camel.Route;
import org.apache.camel.ServiceStatus;
import org.apache.camel.builder.RouteBuilder;
import org.apache.camel.component.mock.MockEndpoint;
import org.apache.camel.spi.RouteController;
import org.apache.camel.spi.SupervisingRouteController;
import org.apache.camel.support.RoutePolicySupport;
import org.apache.camel.test.AvailablePortFinder;
import org.apache.camel.test.infra.activemq.services.ActiveMQEmbeddedServiceBuilder;
import org.apache.camel.test.junit5.CamelTestSupport;
import org.junit.jupiter.api.AfterEach;
import org.junit.jupiter.api.Test;

import static org.junit.jupiter.api.Assertions.assertEquals;
import static org.junit.jupiter.api.Assertions.assertNotEquals;
import static org.junit.jupiter.api.Assertions.fail;

public class PahoReconnectAfterFailureTest extends CamelTestSupport {

    public static final String TESTING_ROUTE_ID = "testingRoute";
    BrokerService broker;

    int mqttPort = AvailablePortFinder.getNextAvailable();
    CountDownLatch routeStartedLatch = new CountDownLatch(1);

    @EndpointInject("mock:test")
    MockEndpoint mock;

    @Override
    protected boolean useJmx() {
        return false;
    }

    @Override
    public void doPreSetup() throws Exception {
        super.doPreSetup();

        broker = ActiveMQEmbeddedServiceBuilder
                .bare()
                .withPersistent(false)
                .build().getBrokerService();

        // Broker will be started later, after camel context is started,
        // to ensure first consumer connection fails
    }

    @Override
    protected CamelContext createCamelContext() throws Exception {
        CamelContext context = super.createCamelContext();
        // Setup supervisor to restart routes because paho consumer
        // is not able to recover automatically on startup
        SupervisingRouteController supervising = context.getRouteController().supervising();
        supervising.setBackOffDelay(500);
        supervising.setIncludeRoutes("paho:*");
        return context;
    }

    @Override
    @AfterEach
    public void tearDown() throws Exception {
        super.tearDown();
        broker.stop();
    }

    @Override
    protected RouteBuilder createRouteBuilder() throws Exception {
        return new RouteBuilder() {
            @Override
            public void configure() throws Exception {

                from("direct:test").to("paho:queue?lazyStartProducer=true&brokerUrl=tcp://localhost:" + mqttPort);
                from("paho:queue?brokerUrl=tcp://localhost:" + mqttPort)
                        .id(TESTING_ROUTE_ID)
                        .routePolicy(new RoutePolicySupport() {
                            @Override
                            public void onStart(Route route) {
                                routeStartedLatch.countDown();
                            }
                        })
                        .to("mock:test");
            }
        };
    }

    @Test
    public void startConsumerShouldReconnectMqttClientAfterFailures() throws Exception {
        RouteController routeController = context.getRouteController();

        assertNotEquals(ServiceStatus.Started, routeController.getRouteStatus(TESTING_ROUTE_ID),
                "Broker down, expecting  route not to be started");

        // Start broker and wait for supervisor to restart route
        // consumer should now connect
        startBroker();
        routeStartedLatch.await(5, TimeUnit.SECONDS);
        assertEquals(ServiceStatus.Started, routeController.getRouteStatus(TESTING_ROUTE_ID),
                "Expecting consumer connected to broker and route started");

        // Given
        String msg = "msg";
        mock.expectedBodiesReceived(msg);

        // When
        template.sendBody("paho:queue?lazyStartProducer=true&brokerUrl=tcp://localhost:" + mqttPort, msg);

        // Then
        mock.assertIsSatisfied();

    }

    @Test
    public void startProducerShouldReconnectMqttClientAfterFailures() throws Exception {
        String msg = "msg";
        mock.expectedBodiesReceived(msg);

        try {
            template.sendBody("direct:test", "notSentMessage");
            fail("Broker is down, paho producer should fail");
        } catch (Exception e) {
            // ignore
        }

        startBroker();
        routeStartedLatch.await(5, TimeUnit.SECONDS);

        template.sendBody("direct:test", msg);

        mock.assertIsSatisfied(10000);
    }

    private void startBroker() throws Exception {
        broker.addConnector("mqtt://localhost:" + mqttPort);
        broker.start();
    }
}


text:
Scientology library: "Fraud, lie, deceit, misrepresentation"
anthony c. "tony" bylsma • boston globe • buffalo news • california department of education • children, youth • clark carr • criminon • cult awareness network (can) (earlier form, citizen's freedom foundation) • evaluation • farah stockman • fraud, lie, deceit, misrepresentation • gary bromwell • gerry marshall • indonesia • lawsuit • mark sommer • narconon (aka scientology drug rehab) • nathan johnson • nerve, touch assist • private investigator(s) • recruitment • richard behar • schools • the way to happiness (twth) • volunteer ministers
9 matching items found between Jan 2005 and Dec 2005. Furthermore, there are 653 matching items for all time not shown.
The Strange Case of Garry Scarff — Jonestown Report
Author(s): Rebecca Moore
Source: Jonestown Report
In 1989, Fielding McGehee and I published The Need for a Second Look at Jonestown, a collection of essays written by those who had been involved with Peoples Temple. In this retrospective volume, people reflected on their experiences of the previous decade, as well as on their understanding of the Temple. Contributors included former members, relatives, and others who had had connections with the Temple, such as news reporters and social activists. Shortly after the book appeared, Chris Hatcher, the psychologist ...
Tag(s): Cult Awareness Network (CAN) (earlier form, Citizen's Freedom Foundation) • Cynthia Kisser • Ford Greene • Fraud, lie, deceit, misrepresentation • Freedom (Scientology magazine) • Garry Scarff • Jonestown Report • Louis Jolyon West • Margaret Thaler Singer • Moonies • Patricia Ryan • Rebecca Moore • [needtotag]
Consultant sentenced in investment scam — Los Angeles Times (California)
Author(s): E. Scott Reckard
Source: Los Angeles Times (California)
A former Southern California business consultant received a four-month prison sentence for conspiring to obstruct a Securities and Exchange Commission investigation of financial advisor Reed E. Slatkin's $593-million investment scam, federal prosecutors said Tuesday. Daniel W. Jacobs helped stall the SEC for more than a year by pretending to represent a Swiss brokerage holding hundreds of millions of dollars in funds from Slatkin investors, according to his plea agreement with the government. Jacobs, 63, who pleaded guilty and cooperated extensively with ...
Tag(s): Daniel W. Jacobs • E. Scott Reckard • Fraud, lie, deceit, misrepresentation • Legal • Los Angeles Times (California) • Reed E. Slatkin
District scrambles to ensure human rights event is religion-free // Officials were unaware of Scientology's role in the international forum at Jordan High in Watts — Los Angeles Times (California)
Author(s): Joel Rubin
Los Angeles city school officials were caught off guard this week by the Church of Scientology's role in an upcoming event at a South Los Angeles high school, which, while not illegal, is considered unusual. On Monday, teenagers from about 25 countries are expected to meet with students at Jordan High School in Watts for a conference on human rights. The gathering is part of a three-day event organized by Youth for Human Rights International — a group with close ties ...
Tag(s): Children, youth • Fraud, lie, deceit, misrepresentation • Joel Rubin • Leisa Collins (aka Leisa Goodman) • Los Angeles Times (California) • Mary Shuttleworth • Schools • Youth for Human Rights International
The way to more questions // Scientology affiliate The Way To Happiness of Glendale teaches honesty in schools but, according to LAPD and others, utilizes dishonest promotions — Pasadena Weekly
More: link
Author(s): Carl Kozlowski
Source: Pasadena Weekly
If a high-ranking LAPD official can be believed, perhaps the Scientology-affiliated The Way To Happiness should take a page from its own teachings. Two of the Glendale-based nonprofit organization's 21 guides to achieving happiness are "Be Worthy of Trust" and "Seek to Live the Truth," neither of which were followed apparently in the group's dealings with the LAPD and a city in Texas. Officials with the group, which over the past two decades has distributed booklets of the same name to ...
Tag(s): Barbara L. Ayash • Carl Kozlowski • Children, youth • Connie de la Garza • Equal Employment Opportunity Commission (EEOC) • Fraud, lie, deceit, misrepresentation • Juan D. Villarreal • Lance Miller • Lawsuit • Michael Downing • Pasadena Weekly • Police • Roosevelt Dorn • Schools • Set A Good Example Foundation (formerly, Concerned Businessmen's Association of America) • The Way to Happiness (TWTH) • Tory "Magoo" Christman • Workplace recruitment
PostScript: When scientologists aren't so clear — Pittsburgh Post-Gazette
Author(s): Virginia Linn
Source: Pittsburgh Post-Gazette
Leaders of the Church of Scientology have long had the reputation of being uncooperative with the media. Still, we were surprised at their tenaciousness in trying to control our stories. Whenever reporters delve into a topic that is even the least bit controversial, we take extra care in making sure we've pulled together as balanced a report as possible. Such was the case on a package of stories published last Sunday on the Church of Scientology, one of the most unusual ...
Tag(s): Bankruptcy • Buffalo News • Chuck Beatty • Cult Awareness Network (CAN) (earlier form, Citizen's Freedom Foundation) • David S. Touretzky • Elizabeth "Beth" Akiyama • Fraud, lie, deceit, misrepresentation • Jason Scott • Lawsuit • Mark Sommer • Pittsburgh Post-Gazette • Private investigator(s) • Richard Behar • Silencing criticism, censorship • TIME Magazine • Virginia Linn • Washington Post • Xenu (Operating Thetan level 3, OT 3, Wall of Fire)
Item contributed by: Ron Sharp
The press vs. Scientology — Salon
Author(s): Joe Strupp
Source: Salon
After years of conflict, the church and the media seem to have reached a truce. Is it because Scientology has become less confrontational — or because the press is scared? For anyone interested in the Church of Scientology, the May 6, 1991, issue of Time magazine remains a milestone in news coverage. For those who back the church, it ran an outrageously biased account that eventually led to a libel suit by the church — later dismissed — and prompted Scientology ...
Tag(s): Alice Chasan • BeliefNet.com • Benjamin Svetkey • Boston Herald • Buffalo News • Cult Awareness Network (CAN) (earlier form, Citizen's Freedom Foundation) • Ed Parkin • Elli Perkins • Entertainment Weekly • Fair game • Fraud, lie, deceit, misrepresentation • Internal Revenue Service (IRS) • J. Gordon Melton • Jeremy Perkins • Joe Strupp • Joel Sappell • Lawrence "Larry" Wollersheim • Lawsuit • Los Angeles Times (California) • Mark Sommer • Nanette Asimov • Private investigator(s) • Richard Behar • Salon • San Francisco Chronicle (California) • Scientology: The Thriving Cult of Greed and Power (article) • St. Petersburg Times (Florida) • Stephen A. Kent • US Weekly • USA Today
Former civilian FDNY official raised money for a questionable 9/11 charity — Firehouse
More: cms.firehouse.com
Author(s): Murray Weiss, Leonard Greene
Source: Firehouse
April 8, 2005 – A former civilian FDNY official raised money for a questionable 9/11 charity with a smokescreen of lies and phony props, including a fake link to former mayor Rudy Giuliani, a bogus uniform and fraudulent valor medals, fire officials are charging. Stephan Hittmann was never entitled to wear a uniform in his civilian job as a director of fire training, but that didn't stop him from buttoning up the dress blues and pinning on bogus medals of valor ...
Tag(s): 9/11 • Firehouse • Fraud, lie, deceit, misrepresentation • Leonard Greene • Murray Weiss • New York Rescue Workers Detoxification Program • Stephan Hittmann
In Indonesia, Some Groups Mix Relief, Religion — Boston Globe
Author(s): Farah Stockman
Source: Boston Globe
BANDA ACEH, Indonesia — In a tent near the center of town, under a banner that reads ''trauma center," volunteer ministers from the Church of Scientology administer their brand of grief counseling to tsunami victims, which includes massages.	In another tent, at a mosque several miles down a main road, members of a militant Islamic group known for attacking bars and nightclubs during Ramadan, the Muslim holy month, prepare to give thousands of homeless people a heavy dose of religious counseling. ...
Tag(s): Boston Globe • Criminon • Farah Stockman • Fraud, lie, deceit, misrepresentation • Gary Bromwell • Indonesia • Nerve, touch assist • Recruitment • The Way to Happiness (TWTH) • Volunteer Ministers
Narconon Drug Abuse Prevention Program Evaluation — California Department of Education
Source: California Department of Education
Tag(s): Anthony C. "Tony" Bylsma • California Department of Education • Clark Carr • Evaluation • Fraud, lie, deceit, misrepresentation • Gerry Marshall • Narconon (aka Scientology drug rehab) • Nathan Johnson


text:
Arnee (, ) era una città del periodo classico e bizantino sita nella regione storica della Licia in Asia Minore:  essa si trovava nel sud-ovest dell'attuale Turchia vicino all'odierna cittadina di Ernez.

La città è menzionata solo in alcune fonti scritte. Numerose iscrizioni, tuttavia, permettono di capirne la storia. Arnee era il sobborgo di una sympoliteia di insediamenti vicini della Licia. Essa era sotto l'influenza della vicina Myra. Sotto Gordiano III Arnee batteva moneta propria. Nella tarda antichità, la città era sede di un vescovo che era subordinato al Metropolita di Myra. Il vescovato titolare di Arnee della Chiesa cattolica romana risale alla diocesi.

I resti della città risalgono principalmente al primo periodo bizantino: tra questi ci sono la cinta muraria ben conservata con torri e due porte, e due chiese all'interno della città. Un'altra chiesa si trovava a ovest, fuori dalle mura della città. Tutte e tre erano basiliche a tre navate con un'abside rotonda rivolta a est la quale ospitava l'altare. Nella terza chiesa, di cui sono sopravvissuti solo pochi resti delle fondazioni, dalla parete sud orientale è emerso un insolito ulteriore abside a pianta rotonda: esso era probabilmente la tomba del fondatore.

Note

Fonti

Siti archeologici della provincia di Adalia
Città antiche della Licia


text:
Tag Archives: L'Heptaméron
Posted by michelinewalker in 16th-century France, 17th-century France, Huguenots, Love
Alexandre Dumas père, L'Heptaméron, la carte de Tendre, La Reine Margot, Mademoiselle de Scudéry, Marguerite de Navarre, Marguerite de Valois-Vendôme
Madame de La Fayette (labibliothèquedesev.wordpress)
I taught La Princesse de Clèves (The Princess of Cleves) year after year for several decades and told my students who the characters were, including their ancestry. It was easy then, but eighteen years later, it is no longer so easy. I remember the main names, but a few names confused me. Some characters have several titles and some characters have the same title. These are hereditary, so it is a matter of lineage.
The Prince of Cleves' father is the Duke of Nevers, but he remains a Clèves (See List of Counts of Dukes of Vendôme, Wikipedia.) Clèves/Kleve is a comté (county) in Germany. Le Chevalier de Guise, the Prince de Clèves' rival, has a brother who is Cardinal of Lorraine, but Cardinal de Lorraine is a title. He remains a Guise. Individuals, mostly aristocrats, can have several titles. Moreover, a Marguerite de Navarre may follow a Marguerite de Navarre. Navarre is a title.
Were it not for the two Marguerites, finding a legitimate heir to the throne of France after the death of Henri III would be difficult. Henri II and Catherine de' Medici had three sons who reigned, but no heir was born to these three sons. However, because Marguerite de Valois-Vendôme was a Queen consort of Navarre, Henri III of Navarre has Bourbon ancestry. He is the son of Antoine de Bourbon, Duke of Vendôme and Jeanne d'Albret, the Queen of Navarre. He was baptised a Catholic and raised as a Huguenot. (See Henri IV of France, Wikipedia.) His ancestor was François de Bourbon-Vendôme. (See List of Counts of Dukes of Vendôme, Wikipedia.) Therefore, Henri III of Navarre can ascend the throne of France as Henri IV of France, when Henri III, King of France and Poland, is murdered without issue.
Portrait of Marguerite d'Angoulême by Jean Clouet, ca. 1527
Portrait of Princess Margaret of Valois by François Clouet, 16th century. Margaret was considered in her time beautiful, cultured, refined and flirtatious: for this, she was called the "pearl of the Valois." (Wikipedia)
Marguerite de Navarre: l'Heptaméron & La Reine Margot
We have two Marguerites de Navarre, but there may be more. Our first Marguerite de Navarre (1492–1549) is Marguerite de Valois-Angoulême, François 1er's sister. This Marguerite de Navarre is the author of an collection of 72 novellas (unfinished) entitled the Heptaméron. She found her inspiration in Giovanni Boccaccio's Decameron (1313–1375), a compendium of novellas told by young people who have fled the plague. The Decameron exerted influence on Madame de La Fayette. Both l'Heptaméron and La Princesse de Clèves describe intrigues at the Court of France.
Our second Marguerite de Navarre (1553-1615), also born a Valois or Marguerite de France, is Alexandre Dumas père's La Reine Margot, but it is unlikely that she was as depraved as Dumas depicted her. This Marguerite is the daughter of Henri II and Catherine de' Medici. She married Henri III of Navarre, whom she did not love and who became Henri IV, King of Navarre and France. He converted to Catholicism. He is remembered for saying that Paris was well worth a Mass: Paris vaut bien une messe. Marguerite de France had a brother named Henri III de France. He was King of France and Poland and was assassinated by Jacques Clément, a "Catholic fanatic," in 1589 (see Henri III of France, Wikipedia). Henri II and Catherine de' Medici had three sons who reigned but there was a second François. He was their last child. He died in 1585, four years before Henri III, King of France, was murdered. Marguerite de Valois protected her husband during the St. Bartholomew's Day Massacre.
So, there are two Marguerite de Navarre, both of whom were initially Marguerite de France, of the House of Valois. "France" is the name given to the children of the King of France. Marguerite de France, the second Marguerite, could not have children, so her marriage to Henri IV was annulled in 1599. She then lived in Paris and befriended Henri IV and his wife, Marie de' Medici. She lived comfortably and had a castle built. Marguerite liked entertaining artists and writers.
As for La Princesse de Clèves' characters, despite the multitude named or mentioned in Madame de La Fayette's novel, few are truly important, although all play a role. The Princesse de Clèves has "digressions" that mirror the main narrative, which, to a certain extent, is a frame story.
La Carte de Tendre, attributed to engraver François Chauveau
The princess of Clèves is the former Mademoiselle de Chartres,
The prince of Clèves is the Princess' husband, whom she marries because he is "moins répugnant," less repulsive, than other men.
The Duke of Nemours is the man the Princesse of Clèves truly loves: inclination. This kind of love is the central river in Mademoiselle de Scudéry's Carte de Tendre, Tendre-sur-Inclination. The map of love shows two other rivers: Tendre-sur-Estime and Tendre-sur-Reconnaissance. The Prince de Clèves dies of grief but the Princesse de Clèves will not marry le Duc de Nemours. She fears that if he has nothing to wish for, his love will die.
The Vidame de Chartres is the recipient of the letter that falls out of the Duke of Nemours' pocket.
Mary Queen of Scots, Marie Stuart, is Queen Dauphine and Queen of France as wife of François II of France.
We will continue to discuss La Princesse de Clèves. but central to its intrigue are her confession (l'aveu) and a letter that falls out of the Duc de Nemours' pocket after un jeu de paume, today's tennis. The Princess of Cleves thinks the Duc de Nemours, whom she loves with a passion, is unfaithful. After reading the letter, she feels so betrayed and jealous that love and jealousy become inextricably linked in her mind.
La Princesse de Clèves, 2 (22 December 2020)
A Lost Post (17 December 2020)
labibliothèquedesev.wordpress
Arcangelo Corelli's Christmas Concerto
Henry II of France by François Clouet


Looking for a part-time or summer job? Come to the library's 4th annual Teen Job Pfair to meet local employers and organizations and learn about local job and volunteer opportunities.
Visit pflugervilletx.gov/teenjobpfair for updated information and job fair tips. Participating employers will be added as they are confirmed.
This event is open to teens ages 14 to 19, but keep in mind that employers set varying minimum age requirements. Even if you are too young to get a job this year, this is a great chance to learn about future job opportunities. Teens do NOT need to register to attend.
Local employers and volunteer organizations interested in participating can register online. Participating employers will be included in our our online and print advertising if they register by January 31, 2019. The final deadline for employer registration is February 15, 2019.


text:
Below you will find term dates for the next three years - 2022 - 2023 and 2023 - 2024. Our school has allocated a 2 week half term in May/June to give opportunities to families to take a cheaper two week holiday. Please ensure that all family holidays are taken within the school holiday periods. Thank you.
Term Dates 2022-2023.pdf Term Dates 2023-2024.pdf


text:
Canadians & the COVID-19 Shot: Patient and Mostly Confident
Listen to David Coletto's new podcast inFocus with David Coletto
Listen to Bruce Anderson & Peter Mansbridge Wednesday's on Smoke, Mirrors and the Truth, a podcast within Peter Mansbridge's podcast The Bridge.
Roughly two out of three Canadians expect to be offered a COVID-19 vaccine shot before the end of September timetable discussed by the Prime Minister, and about 60% of them consider that timing to be acceptable or better.
One in five people don't expect to have access to a shot until 2022, and 58% of that group considers that timing acceptable.
The patterns in these data suggest that if the government meets that timetable most people will be satisfied with that, although it is reasonable to assume that these perceptions will fluctuate depending on a number of factors. People may find themselves happier once they have the shot, or frustrated if they feel that the pace relative to the United States or other countries is lagging. Alternatively, their mood might change based on the health of the economy and how quickly they are able to return to more normal activities.
It seems reasonable to assume based on these expectations, and the announcement by the federal government last week about accelerating Pfizer shipments and the authorization of the Johnson and Johnson vaccine, that the government's vaccine roll-out may outperform what more than half of the population expects.
Based on their current expectations of when a vaccine will be available to them personally, 40% believing that the timing they expect to be offered a vaccine will be unacceptably slow. Older people are somewhat more unhappy than younger people but the difference is about five percentage points. The most dissatisfied are Conservative voters, 50% of whom say the timing will be too slow. Among NDP voters 42% are anticipating too slow an availability.
VACCINE HESITANCY
In our polling, 4% say they have had the first shot, and 58% say they will take the shot as soon as it is available to them. That leaves a total of 38% exhibiting some form or degree of hesitancy, including 8% who say they will not take the vaccine under any circumstances, 9% prefer not to but could be convinced, and 21% who expect to take the vaccine but would prefer to wait a bit before taking it.
Those most likely to exhibit hesitancy are people under 45, particularly women under 45, as well as those with less formal education, and Conservative and Green Party voters.
There are slightly different levels of confidence in the different vaccines that have been approved for use in Canada. Pfizer and Moderna enjoy equal levels of public confidence, while Johnson and Johnson is slightly lower because there is a higher "unsure" level. Astra Zeneca has a lower level of public confidence, especially among Conservative voters and women.
According to Bruce Anderson: "For most people, getting access to a vaccine is a crucial priority in their lives, and hesitancy levels have come down a bit as people see vaccines being administered around the world in increasing amounts.
For the federal government, the public remains relatively patient with the timetable laid out by the Prime Minister and improvements on that timetable are likely to be met with public appreciation. The data about Astra Zeneca's vaccine is a clear signal of how closely attentive people are to vaccine safety questions and thus that confidence is always a bit fragile and momentum could be put at risk if doubt about safety becomes a more prominent political discussion."
The survey was conducted with 2,000 Canadian adults from March 2 to 5, 2021. A random sample of panelists were invited to complete the survey from a set of partner panels based on the Lucid exchange platform. These partners are typically double opt-in survey panels, blended to manage out potential skews in the data from a single source.
And don't miss any of our research and analysis, plus get our weekly Worth A Look newsletter. Sign up today.
Tags: Canadian politicsCOVID-19Vaccine hesitancyVaccine timing


text:
SBU News > Stony Brook Matters > Main University > Forbes Ranks Stony Brook Among Top 25 STEM Colleges
Main UniversityMedicine and ResearchMedicine TodayStony Brook Matters
Stony Brook University was one of just seven public colleges and universities named to Forbes magazine's list of the "Top 25 STEM Colleges" in the United States, part of the magazine's annual list of "America's Top Colleges." Stony Brook was ranked 21st on the list, which is comprised of institutions where more than half of students major in science, technology, engineering and math (STEM) disciplines.
Read article on Forbes.
Stony Brook Named by Forbes as One of Best Universities to Work For
Alumni Spotlight StoryFaculty/Student SpotlightsFeatured StoryGiving BackStony Brook MattersStudentStudent SpotlightWellness
Volunteer Ambulance Corps Marks a Half-Century of Community Service
For the all-student Stony Brook Volunteer Ambulance Corps (SBVAC), it began with a Volkswagen bus and a Cadillac. In 1970, frustrated by long response times from local ambulance corps, Stony Brook University students...
Alumni Spotlight StoryAwards and HonorsMedicineMedicine Alumni NewsMedicine and ResearchNursing Alumni NewsStony Brook Matters
Stony Brook Named One of America's 100 Best Hospitals for 2020
Stony Brook is the only hospital on Long Island to receive this distinction for the past two consecutive years and among only five hospitals in New York State this year.
Alumni Hottest StoriesArts & EntertainmentCOVID-19Featured StoryStony Brook Matters
SBU Cultural Leaders View Post-Pandemic Performing Arts
"Think about how much film, literature, music and visual arts people are consuming during their sheltering in place," said Ken Weitzman, Associate Professor, Dramatic Writing, Stony Brook University Department of...